Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-04

AUTHORS

Sun Young Rha, Yong Hwa Moon, Hei Chul Jeung, Yong Tae Kim, Joo Hyuk Sohn, Woo Ick Yang, Chang Ok Suh, Gwi Eon Kim, Jae Kyung Roh, Hyun Cheol Chung

ABSTRACT

PurposesWe evaluated the efficacy and tolerability of gemcitabine monotherapy in heavily pretreated, breast cancer patients as salvage chemotherapy.MethodsA weekly infusion of gemcitabine at 850 mg/m2for 30 min, for 3 of every 4 weeks, was introduced in advanced breast cancer patients who had failed previous doxorubicin and taxane based chemotherapy. There was no dose modification, and the treatment was delayed until the leukopenia was recovered with G-CSF support. The efficacy was evaluated every three cycles and the treatment was continued until either disease progression or 12 cycles.ResultsOf 41 enrolled patients, 38 were evaluable with a median age of 47. Total 178 cycles of gemcitabine was administered and the relative dose intensity was 89. The toxicity was mild with 12 of grade III neutropenia and 14 of grade III/IV thrombocytopenia without clinical symptoms. The response rate was 20 (8/38), comprising two complete and six partial responses. The median response duration and overall survival were 9 (2–25) and 11 months, respectively. The overall survival of 12 months was better in the third line patients than the 7 months in the fourth line treatment group.ConclusionGemcitabine monotherapy is effective and safe as salvage treatment in heavily pretreated, breast cancer patients. More... »

PAGES

215-221

References to SciGraph publications

  • 1998-10. Gemcitabine for palliative treatment in metastatic breast cancer in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10549-004-2468-4

    DOI

    http://dx.doi.org/10.1007/s10549-004-2468-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1027872686

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/15830134


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antimetabolites, Antineoplastic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Deoxycytidine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Granulocyte Colony-Stimulating Factor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infusions, Intravenous", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Metastasis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Salvage Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea", 
                "Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rha", 
            "givenName": "Sun Young", 
            "id": "sg:person.01036404665.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404665.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea", 
                "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Moon", 
            "givenName": "Yong Hwa", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jeung", 
            "givenName": "Hei Chul", 
            "id": "sg:person.01043564241.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043564241.87"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kim", 
            "givenName": "Yong Tae", 
            "id": "sg:person.01013045214.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013045214.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sohn", 
            "givenName": "Joo Hyuk", 
            "id": "sg:person.0661267733.85", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661267733.85"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Pathology, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Pathology, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yang", 
            "givenName": "Woo Ick", 
            "id": "sg:person.016025552634.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016025552634.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Suh", 
            "givenName": "Chang Ok", 
            "id": "sg:person.016501460022.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016501460022.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kim", 
            "givenName": "Gwi Eon", 
            "id": "sg:person.01311370625.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311370625.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea", 
                "Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea", 
                "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Roh", 
            "givenName": "Jae Kyung", 
            "id": "sg:person.0767622633.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea", 
              "id": "http://www.grid.ac/institutes/grid.15444.30", 
              "name": [
                "Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea", 
                "Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea", 
                "Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea", 
                "Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chung", 
            "givenName": "Hyun Cheol", 
            "id": "sg:person.016554426212.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s004320050210", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023164289", 
              "https://doi.org/10.1007/s004320050210"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2005-04", 
        "datePublishedReg": "2005-04-01", 
        "description": "PurposesWe evaluated the efficacy and tolerability of gemcitabine monotherapy in heavily pretreated, breast cancer patients as salvage chemotherapy.MethodsA weekly infusion of gemcitabine at 850\u00a0mg/m2for 30\u00a0min, for 3 of every 4\u00a0weeks, was introduced in advanced breast cancer patients who had failed previous doxorubicin and taxane based chemotherapy. There was no dose modification, and the treatment was delayed until the leukopenia was recovered with G-CSF support. The efficacy was evaluated every three cycles and the treatment was continued until either disease progression or 12 cycles.ResultsOf 41 enrolled patients, 38 were evaluable with a median age of 47. Total 178 cycles of gemcitabine was administered and the relative dose intensity was 89. The toxicity was mild with 12 of grade III neutropenia and 14 of grade III/IV thrombocytopenia without clinical symptoms. The response rate was 20 (8/38), comprising two complete and six partial responses. The median response duration and overall survival were 9 (2\u201325) and 11\u00a0months, respectively. The overall survival of 12\u00a0months was better in the third line patients than the 7\u00a0months in the fourth line treatment group.ConclusionGemcitabine monotherapy is effective and safe as salvage treatment in heavily pretreated, breast cancer patients.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s10549-004-2468-4", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1092777", 
            "issn": [
              "0167-6806", 
              "1573-7217"
            ], 
            "name": "Breast Cancer Research and Treatment", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "90"
          }
        ], 
        "keywords": [
          "breast cancer patients", 
          "cancer patients", 
          "salvage chemotherapy", 
          "gemcitabine monotherapy", 
          "overall survival", 
          "grade III/IV thrombocytopenia", 
          "advanced breast cancer patients", 
          "cycles of gemcitabine", 
          "relative dose intensity", 
          "grade III neutropenia", 
          "median response duration", 
          "third-line patients", 
          "G-CSF support", 
          "metastatic breast cancer", 
          "previous doxorubicin", 
          "salvage treatment", 
          "weekly infusions", 
          "dose modification", 
          "dose intensity", 
          "partial response", 
          "median age", 
          "clinical symptoms", 
          "disease progression", 
          "line patients", 
          "breast cancer", 
          "response duration", 
          "treatment groups", 
          "patients", 
          "response rate", 
          "monotherapy", 
          "chemotherapy", 
          "months", 
          "gemcitabine", 
          "treatment", 
          "efficacy", 
          "survival", 
          "PurposesWe", 
          "tolerability", 
          "leukopenia", 
          "neutropenia", 
          "thrombocytopenia", 
          "infusion", 
          "taxanes", 
          "symptoms", 
          "cancer", 
          "progression", 
          "weeks", 
          "age", 
          "doxorubicin", 
          "toxicity", 
          "duration", 
          "group", 
          "min", 
          "response", 
          "rate", 
          "cycle", 
          "support", 
          "modification", 
          "intensity"
        ], 
        "name": "Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer", 
        "pagination": "215-221", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1027872686"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10549-004-2468-4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "15830134"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10549-004-2468-4", 
          "https://app.dimensions.ai/details/publication/pub.1027872686"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:23", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_409.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s10549-004-2468-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-004-2468-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-004-2468-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-004-2468-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-004-2468-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    250 TRIPLES      22 PREDICATES      101 URIs      92 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10549-004-2468-4 schema:about N029bfbbbab824caeaa99f73c0e1b1a37
    2 N04ba296ec881479bb7ed360a65417b94
    3 N0c3b7f53ab15496c85018f084b0eaa03
    4 N0d98305f55c64d9993eddf7603a7b974
    5 N119fb39414d4471b90fc6f97d68890b5
    6 N28b55d22d33c49ed8c1b9e8157c97dbe
    7 N39657bc55e904164bef7628830918bcc
    8 N41e86c9d622f4343a4b5a68113cac8b5
    9 N99073d17dffd4bc1910e3b173eab82a8
    10 Nb0db0d6e8bdf4626b9aa8469a7e2692d
    11 Nb6d0f96c7e2d4dde8f1d7ee0fe7b3f07
    12 Nd72c96db1e88487986caa0f0aabda60b
    13 Nee339aaaebff4abaa2de53bc243d1d5f
    14 Nf3c6bcf21dbf452892b825502d00bcad
    15 anzsrc-for:11
    16 anzsrc-for:1112
    17 schema:author N67f34d0d2e0043049324261e2c716c38
    18 schema:citation sg:pub.10.1007/s004320050210
    19 schema:datePublished 2005-04
    20 schema:datePublishedReg 2005-04-01
    21 schema:description PurposesWe evaluated the efficacy and tolerability of gemcitabine monotherapy in heavily pretreated, breast cancer patients as salvage chemotherapy.MethodsA weekly infusion of gemcitabine at 850 mg/m2for 30 min, for 3 of every 4 weeks, was introduced in advanced breast cancer patients who had failed previous doxorubicin and taxane based chemotherapy. There was no dose modification, and the treatment was delayed until the leukopenia was recovered with G-CSF support. The efficacy was evaluated every three cycles and the treatment was continued until either disease progression or 12 cycles.ResultsOf 41 enrolled patients, 38 were evaluable with a median age of 47. Total 178 cycles of gemcitabine was administered and the relative dose intensity was 89. The toxicity was mild with 12 of grade III neutropenia and 14 of grade III/IV thrombocytopenia without clinical symptoms. The response rate was 20 (8/38), comprising two complete and six partial responses. The median response duration and overall survival were 9 (2–25) and 11 months, respectively. The overall survival of 12 months was better in the third line patients than the 7 months in the fourth line treatment group.ConclusionGemcitabine monotherapy is effective and safe as salvage treatment in heavily pretreated, breast cancer patients.
    22 schema:genre article
    23 schema:inLanguage en
    24 schema:isAccessibleForFree false
    25 schema:isPartOf N0436ff70f03b463c9225ed1e8895064e
    26 N84a50268ae5e46fca8ab6d0f9c071492
    27 sg:journal.1092777
    28 schema:keywords G-CSF support
    29 PurposesWe
    30 advanced breast cancer patients
    31 age
    32 breast cancer
    33 breast cancer patients
    34 cancer
    35 cancer patients
    36 chemotherapy
    37 clinical symptoms
    38 cycle
    39 cycles of gemcitabine
    40 disease progression
    41 dose intensity
    42 dose modification
    43 doxorubicin
    44 duration
    45 efficacy
    46 gemcitabine
    47 gemcitabine monotherapy
    48 grade III neutropenia
    49 grade III/IV thrombocytopenia
    50 group
    51 infusion
    52 intensity
    53 leukopenia
    54 line patients
    55 median age
    56 median response duration
    57 metastatic breast cancer
    58 min
    59 modification
    60 monotherapy
    61 months
    62 neutropenia
    63 overall survival
    64 partial response
    65 patients
    66 previous doxorubicin
    67 progression
    68 rate
    69 relative dose intensity
    70 response
    71 response duration
    72 response rate
    73 salvage chemotherapy
    74 salvage treatment
    75 support
    76 survival
    77 symptoms
    78 taxanes
    79 third-line patients
    80 thrombocytopenia
    81 tolerability
    82 toxicity
    83 treatment
    84 treatment groups
    85 weekly infusions
    86 weeks
    87 schema:name Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
    88 schema:pagination 215-221
    89 schema:productId N474f22049f92458c9bd96ac4d4c77a35
    90 Na202c27cba884f3b8fef6820a78e651c
    91 Nefaa7de223884db5b4e3176543cb667b
    92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027872686
    93 https://doi.org/10.1007/s10549-004-2468-4
    94 schema:sdDatePublished 2022-05-20T07:23
    95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    96 schema:sdPublisher N5e8c4a19d5604072a7c86087075bc997
    97 schema:url https://doi.org/10.1007/s10549-004-2468-4
    98 sgo:license sg:explorer/license/
    99 sgo:sdDataset articles
    100 rdf:type schema:ScholarlyArticle
    101 N029bfbbbab824caeaa99f73c0e1b1a37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Treatment Outcome
    103 rdf:type schema:DefinedTerm
    104 N0436ff70f03b463c9225ed1e8895064e schema:volumeNumber 90
    105 rdf:type schema:PublicationVolume
    106 N04ba296ec881479bb7ed360a65417b94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Humans
    108 rdf:type schema:DefinedTerm
    109 N0c3b7f53ab15496c85018f084b0eaa03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Adult
    111 rdf:type schema:DefinedTerm
    112 N0d98305f55c64d9993eddf7603a7b974 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Salvage Therapy
    114 rdf:type schema:DefinedTerm
    115 N119fb39414d4471b90fc6f97d68890b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Female
    117 rdf:type schema:DefinedTerm
    118 N151d1f8bda7a4691ad5a456d20a5f031 schema:affiliation grid-institutes:grid.15444.30
    119 schema:familyName Moon
    120 schema:givenName Yong Hwa
    121 rdf:type schema:Person
    122 N28b55d22d33c49ed8c1b9e8157c97dbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Neoplasm Metastasis
    124 rdf:type schema:DefinedTerm
    125 N2af3950e107d47a98ddb8dbaee6cb361 rdf:first sg:person.01043564241.87
    126 rdf:rest Nb7646addbe1648ad9631016ced13ff24
    127 N39657bc55e904164bef7628830918bcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Breast Neoplasms
    129 rdf:type schema:DefinedTerm
    130 N41e86c9d622f4343a4b5a68113cac8b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Aged
    132 rdf:type schema:DefinedTerm
    133 N474f22049f92458c9bd96ac4d4c77a35 schema:name doi
    134 schema:value 10.1007/s10549-004-2468-4
    135 rdf:type schema:PropertyValue
    136 N5e8c4a19d5604072a7c86087075bc997 schema:name Springer Nature - SN SciGraph project
    137 rdf:type schema:Organization
    138 N67d6762b770d4a50b148baf0279a7117 rdf:first sg:person.016025552634.33
    139 rdf:rest N6d9588b7131e438aa1ed2971b9524bd0
    140 N67f34d0d2e0043049324261e2c716c38 rdf:first sg:person.01036404665.54
    141 rdf:rest N93bb1e84d5d643229ddb8f9f2e9c4866
    142 N6d9588b7131e438aa1ed2971b9524bd0 rdf:first sg:person.016501460022.74
    143 rdf:rest Nf6be83ab19f44b978c0c90ef4c0e0b14
    144 N84a50268ae5e46fca8ab6d0f9c071492 schema:issueNumber 3
    145 rdf:type schema:PublicationIssue
    146 N93bb1e84d5d643229ddb8f9f2e9c4866 rdf:first N151d1f8bda7a4691ad5a456d20a5f031
    147 rdf:rest N2af3950e107d47a98ddb8dbaee6cb361
    148 N99073d17dffd4bc1910e3b173eab82a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Infusions, Intravenous
    150 rdf:type schema:DefinedTerm
    151 Na202c27cba884f3b8fef6820a78e651c schema:name pubmed_id
    152 schema:value 15830134
    153 rdf:type schema:PropertyValue
    154 Nb0db0d6e8bdf4626b9aa8469a7e2692d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Survival Analysis
    156 rdf:type schema:DefinedTerm
    157 Nb6d0f96c7e2d4dde8f1d7ee0fe7b3f07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Antimetabolites, Antineoplastic
    159 rdf:type schema:DefinedTerm
    160 Nb7646addbe1648ad9631016ced13ff24 rdf:first sg:person.01013045214.98
    161 rdf:rest Nfb7e91ddacfe4258a1a7fdff05d3e184
    162 Nd72c96db1e88487986caa0f0aabda60b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Granulocyte Colony-Stimulating Factor
    164 rdf:type schema:DefinedTerm
    165 Nd7838d4d82d841689cd8acac19cb5645 rdf:first sg:person.0767622633.82
    166 rdf:rest Nff067216e942430487bb38b09a9fd19e
    167 Nee339aaaebff4abaa2de53bc243d1d5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Deoxycytidine
    169 rdf:type schema:DefinedTerm
    170 Nefaa7de223884db5b4e3176543cb667b schema:name dimensions_id
    171 schema:value pub.1027872686
    172 rdf:type schema:PropertyValue
    173 Nf3c6bcf21dbf452892b825502d00bcad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Middle Aged
    175 rdf:type schema:DefinedTerm
    176 Nf6be83ab19f44b978c0c90ef4c0e0b14 rdf:first sg:person.01311370625.22
    177 rdf:rest Nd7838d4d82d841689cd8acac19cb5645
    178 Nfb7e91ddacfe4258a1a7fdff05d3e184 rdf:first sg:person.0661267733.85
    179 rdf:rest N67d6762b770d4a50b148baf0279a7117
    180 Nff067216e942430487bb38b09a9fd19e rdf:first sg:person.016554426212.74
    181 rdf:rest rdf:nil
    182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    183 schema:name Medical and Health Sciences
    184 rdf:type schema:DefinedTerm
    185 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    186 schema:name Oncology and Carcinogenesis
    187 rdf:type schema:DefinedTerm
    188 sg:journal.1092777 schema:issn 0167-6806
    189 1573-7217
    190 schema:name Breast Cancer Research and Treatment
    191 schema:publisher Springer Nature
    192 rdf:type schema:Periodical
    193 sg:person.01013045214.98 schema:affiliation grid-institutes:grid.15444.30
    194 schema:familyName Kim
    195 schema:givenName Yong Tae
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013045214.98
    197 rdf:type schema:Person
    198 sg:person.01036404665.54 schema:affiliation grid-institutes:grid.15444.30
    199 schema:familyName Rha
    200 schema:givenName Sun Young
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404665.54
    202 rdf:type schema:Person
    203 sg:person.01043564241.87 schema:affiliation grid-institutes:grid.15444.30
    204 schema:familyName Jeung
    205 schema:givenName Hei Chul
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043564241.87
    207 rdf:type schema:Person
    208 sg:person.01311370625.22 schema:affiliation grid-institutes:grid.15444.30
    209 schema:familyName Kim
    210 schema:givenName Gwi Eon
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311370625.22
    212 rdf:type schema:Person
    213 sg:person.016025552634.33 schema:affiliation grid-institutes:grid.15444.30
    214 schema:familyName Yang
    215 schema:givenName Woo Ick
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016025552634.33
    217 rdf:type schema:Person
    218 sg:person.016501460022.74 schema:affiliation grid-institutes:grid.15444.30
    219 schema:familyName Suh
    220 schema:givenName Chang Ok
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016501460022.74
    222 rdf:type schema:Person
    223 sg:person.016554426212.74 schema:affiliation grid-institutes:grid.15444.30
    224 schema:familyName Chung
    225 schema:givenName Hyun Cheol
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74
    227 rdf:type schema:Person
    228 sg:person.0661267733.85 schema:affiliation grid-institutes:grid.15444.30
    229 schema:familyName Sohn
    230 schema:givenName Joo Hyuk
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661267733.85
    232 rdf:type schema:Person
    233 sg:person.0767622633.82 schema:affiliation grid-institutes:grid.15444.30
    234 schema:familyName Roh
    235 schema:givenName Jae Kyung
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82
    237 rdf:type schema:Person
    238 sg:pub.10.1007/s004320050210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023164289
    239 https://doi.org/10.1007/s004320050210
    240 rdf:type schema:CreativeWork
    241 grid-institutes:grid.15444.30 schema:alternateName Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    242 Pathology, Yonsei University College of Medicine, Seoul, Korea
    243 Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
    244 schema:name Brain Korea 21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Korea
    245 Cancer Metastasis Research Center, Yonsei University College of Medicine, Seoul, Korea
    246 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
    247 Pathology, Yonsei University College of Medicine, Seoul, Korea
    248 Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea
    249 Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
    250 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...